Beijing Leadman Biochemistry Co Ltd Net Asset Quality Index
Beijing Leadman Biochemistry Co Ltd net asset quality index. Beijing Leadman Biochemistry Co Ltd (300289) has a Net Asset Quality Index of 94.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.76 Billion minus total liabilities of CN¥97.10 Million yields net assets of CN¥1.67 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Beijing Leadman Biochemistry Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Beijing Leadman Biochemistry Co Ltd (2008–2025)
Net asset quality index of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. This chart shows how Beijing Leadman Biochemistry Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 94.5%, representing net assets of CN¥1.67 Billion against total assets of CN¥1.76 Billion CNY. Check Beijing Leadman Biochemistry Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Beijing Leadman Biochemistry Co Ltd Net Asset Quality Index by Year (2008–2025)
Beijing Leadman Biochemistry Co Ltd net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Beijing Leadman Biochemistry Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Beijing Leadman Biochemistry Co Ltd (300289) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.1% | CN¥1.67 Billion | CN¥1.78 Billion | CN¥105.46 Million | ▼ -0.2 pp |
| 2024 | 94.3% | CN¥1.72 Billion | CN¥1.82 Billion | CN¥103.84 Million | ▲ +1.2 pp |
| 2023 | 93.1% | CN¥1.80 Billion | CN¥1.94 Billion | CN¥133.77 Million | ▲ +3.9 pp |
| 2022 | 89.2% | CN¥1.78 Billion | CN¥2.00 Billion | CN¥216.67 Million | ▲ +4.9 pp |
| 2021 | 84.2% | CN¥1.98 Billion | CN¥2.35 Billion | CN¥370.30 Million | ▼ -0.4 pp |
| 2020 | 84.7% | CN¥1.38 Billion | CN¥1.63 Billion | CN¥249.92 Million | ▲ +0.1 pp |
| 2019 | 84.6% | CN¥1.45 Billion | CN¥1.71 Billion | CN¥264.18 Million | ▲ +1.5 pp |
| 2018 | 83.1% | CN¥1.44 Billion | CN¥1.73 Billion | CN¥291.80 Million | ▲ +1.9 pp |
| 2017 | 81.3% | CN¥1.43 Billion | CN¥1.75 Billion | CN¥328.73 Million | ▲ +0.9 pp |
| 2016 | 80.4% | CN¥1.34 Billion | CN¥1.66 Billion | CN¥326.13 Million | ▲ +4.4 pp |
| 2015 | 76.0% | CN¥1.26 Billion | CN¥1.66 Billion | CN¥398.76 Million | ▲ +8.3 pp |
| 2014 | 67.6% | CN¥1.09 Billion | CN¥1.62 Billion | CN¥523.48 Million | ▼ -0.8 pp |
| 2013 | 68.4% | CN¥851.12 Million | CN¥1.24 Billion | CN¥392.86 Million | ▲ +1.1 pp |
| 2012 | 67.3% | CN¥761.02 Million | CN¥1.13 Billion | CN¥369.17 Million | ▲ +7.0 pp |
| 2011 | 60.4% | CN¥220.77 Million | CN¥365.66 Million | CN¥144.89 Million | ▼ -1.4 pp |
| 2010 | 61.7% | CN¥159.72 Million | CN¥258.71 Million | CN¥98.99 Million | ▼ -7.1 pp |
| 2009 | 68.8% | CN¥105.32 Million | CN¥153.00 Million | CN¥47.68 Million | ▼ -4.8 pp |
| 2008 | 73.7% | CN¥83.90 Million | CN¥113.91 Million | CN¥30.01 Million | — |